Perceptions and Practices of Key Worker Stakeholder Groups in Hospital Animal-Assisted Intervention Programs on Occupational Benefits and Perceived Risks.

Animal-assisted interventions human health infectious disease risk occupational health

Journal

People and animals (West Lafayette, IN)
ISSN: 2575-9078
Titre abrégé: People Anim
Pays: United States
ID NLM: 9918401188806676

Informations de publication

Date de publication:
2022
Historique:
entrez: 29 6 2022
pubmed: 30 6 2022
medline: 30 6 2022
Statut: ppublish

Résumé

Animal-assisted intervention (AAI) programs, used widely for patient benefit, have increasingly been used for healthcare workers (HCW) to reduce occupational stress. However, there are barriers to these programs which limit their utilization, for both patients and HCW, specifically infectious disease concerns. The aim of the research project is to identify barriers and facilitators to AAI program use for healthcare worker benefit, and determine knowledge, beliefs, and practices regarding infectious disease risk and control policies, in order to understand the contextual parameters of program implementation. We collected perceptions of key stakeholders involved with hospital AAI programs (HCW and AAI workers) through semi-structured in-depth interviews. We used framework analysis to guide thematic coding, completed independently by three researchers. We interviewed 37 participants in this study. We divided our themes into two topic areas: program use for HCW and perceived infectious disease risk. Use for healthcare workers included perspectives on the benefits for HCW and program barriers and facilitators (specifically collaboration and leadership). Perceived risk included opinions on infection concerns with AAI, thoughts on control measures to reduce this risk, and responsibility for safety during these programs. While significant benefits were reported for HCW, they were limited by administrative barriers and hazard concerns. Facilitators to surmount these barriers are best implemented with collaboration across the hospital and appropriate leadership roles to direct safe program implementation. By addressing these barriers through targeted facilitators in the form of evidence-backed guidelines, AAI programs can be used to benefit both patients and HCW.

Sections du résumé

Background UNASSIGNED
Animal-assisted intervention (AAI) programs, used widely for patient benefit, have increasingly been used for healthcare workers (HCW) to reduce occupational stress. However, there are barriers to these programs which limit their utilization, for both patients and HCW, specifically infectious disease concerns. The aim of the research project is to identify barriers and facilitators to AAI program use for healthcare worker benefit, and determine knowledge, beliefs, and practices regarding infectious disease risk and control policies, in order to understand the contextual parameters of program implementation.
Methods UNASSIGNED
We collected perceptions of key stakeholders involved with hospital AAI programs (HCW and AAI workers) through semi-structured in-depth interviews. We used framework analysis to guide thematic coding, completed independently by three researchers.
Results UNASSIGNED
We interviewed 37 participants in this study. We divided our themes into two topic areas: program use for HCW and perceived infectious disease risk. Use for healthcare workers included perspectives on the benefits for HCW and program barriers and facilitators (specifically collaboration and leadership). Perceived risk included opinions on infection concerns with AAI, thoughts on control measures to reduce this risk, and responsibility for safety during these programs.
Conclusions UNASSIGNED
While significant benefits were reported for HCW, they were limited by administrative barriers and hazard concerns. Facilitators to surmount these barriers are best implemented with collaboration across the hospital and appropriate leadership roles to direct safe program implementation. By addressing these barriers through targeted facilitators in the form of evidence-backed guidelines, AAI programs can be used to benefit both patients and HCW.

Identifiants

pubmed: 35765567
pmc: PMC9235541
mid: NIHMS1805346
pii:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : NICHD NIH HHS
ID : R01 HD097692
Pays : United States
Organisme : NIOSH CDC HHS
ID : T42 OH008428
Pays : United States

Références

Am J Infect Control. 2014 Apr;42(4):405-11
pubmed: 24559596
Front Vet Sci. 2020 Feb 07;7:35
pubmed: 32118059
JBI Libr Syst Rev. 2010;8(23):917-971
pubmed: 27819952
Stress Health. 2018 Oct;34(4):477-489
pubmed: 29882342
Complement Ther Clin Pract. 2018 Nov;33:49-55
pubmed: 30396626
PLoS One. 2016 Jul 08;11(7):e0159015
pubmed: 27391946
Eur J Integr Med. 2016 Oct;8(5):695-706
pubmed: 32362955
Infect Control Hosp Epidemiol. 2008 Apr;29(4):333-41
pubmed: 18462146
Am J Infect Control. 2017 Aug 1;45(8):883-887
pubmed: 28673680
PLoS One. 2018 Apr 25;13(4):e0195039
pubmed: 29694375
Infect Control Hosp Epidemiol. 2015 May;36(5):495-516
pubmed: 25998315
Nurs Health Sci. 2010 Sep 1;12(3):369-74
pubmed: 20727089
Disabil Rehabil. 2012;34(18):1526-34
pubmed: 22324733
BMC Fam Pract. 2018 May 10;19(1):59
pubmed: 29747579
BMC Med Res Methodol. 2013 Sep 18;13:117
pubmed: 24047204
Lancet. 2001 Aug 11;358(9280):483-8
pubmed: 11513933
Complement Ther Med. 2014 Apr;22(2):371-90
pubmed: 24731910
Front Vet Sci. 2020 Feb 18;7:70
pubmed: 32133378
J Am Vet Med Assoc. 2009 Jun 1;234(11):1404-17
pubmed: 19480620
Psychol Rep. 2005 Jun;96(3 Pt 1):713-29
pubmed: 16050629
Complement Ther Clin Pract. 2020 May;39:101145
pubmed: 32379677
PLoS One. 2017 Dec 4;12(12):e0188418
pubmed: 29200422

Auteurs

Kathryn R Dalton (KR)

Johns Hopkins University Bloomberg School of Public Health, Department of Environmental Health and Engineering, Baltimore Maryland.

William Altekruse (W)

University of Maryland Baltimore, School of Social Work.

Peter Campbell (P)

University of Maryland Baltimore, School of Medicine.

Kathy Ruble (K)

Johns Hopkins University School of Medicine, Department of Pediatric Oncology, Baltimore Maryland.

Karen C Carroll (KC)

Johns Hopkins University School of Medicine, Department of Pathology, Division of Medical Microbiology, Baltimore Maryland.

Roland J Thorpe (RJ)

Johns Hopkins University Bloomberg School of Public Health, Department of Health, Behavior and Society, Baltimore Maryland.

Jacqueline Agnew (J)

Johns Hopkins University Bloomberg School of Public Health, Department of Environmental Health and Engineering, Baltimore Maryland.

Meghan F Davis (MF)

Johns Hopkins University Bloomberg School of Public Health, Department of Environmental Health and Engineering, Baltimore Maryland.
Johns Hopkins Medicine, Department of Molecular and Comparative Pathobiology, Baltimore Maryland.

Classifications MeSH